Back
Arcturus Therapeutics Holdings Stock Predictions
Could This Stock Under $5 Be Your Biggest Opportunity?
Click here to learn more.
Sell
32
ARCT
Arcturus Therapeutics Holdings
Last Price:
$19.05
Seasonality Move:
3.48%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Arcturus Therapeutics Holdings Stock Forecast
-
Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 22.1% based on the past 11 years of stock performance.
-
Arcturus Therapeutics Holdings has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
-
Is Arcturus Therapeutics Holdings Stock Undervalued?The current Arcturus Therapeutics Holdings [ARCT] share price is $17.94. The Score for ARCT is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.
-
ARCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Arcturus Therapeutics Holdings Stock Go Up Next Year?
-
Over the next 52 weeks, Arcturus Therapeutics Holdings has on average historically risen by 22.1% based on the past 11 years of stock performance.
Arcturus Therapeutics Holdings Stock Rating
Sell
32
Arcturus Therapeutics Holdings (ARCT)
is a Sell
Is Arcturus Therapeutics Holdings overpriced?
-
Arcturus Therapeutics Holdings has risen higher in 4 of those 11 years over the subsequent 52-week period, corresponding to a historical accuracy of 36.36%
Arcturus Therapeutics Holdings Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
arcturusrx.com
52-Week Data
52-Week High:
45.00
52-Week Low:
14.30
Prediction Charts
Market Cap:
485.9M
Price in USD:
17.94
Volume:
323.5K
Beta:
2.52
Technical Analysis
SMA50:
17.70
SMA100:
19.42
SMA200:
23.83
52-Wk Change:
-42.81%
Stock Predictions
-
Is Arcturus Therapeutics Holdings stock public?Yes, Arcturus Therapeutics Holdings is a publicly traded company.
-
What is the Arcturus Therapeutics Holdings stock quote today?The Arcturus Therapeutics Holdings stock price is 17.94 USD today.
-
How to buy Arcturus Therapeutics Holdings stock online?You can buy Arcturus Therapeutics Holdings shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-13 | 17.34 | 17.21 | 17.51 | 16.67 |
| Dec-16 | 17.17 | 16.24 | 17.48 | 16.10 |
| Dec-17 | 16.85 | 15.73 | 16.85 | 15.55 |
| Dec-18 | 15.75 | 14.82 | 16.13 | 14.35 |
| Dec-19 | 15.24 | 14.84 | 15.71 | 14.30 |
| Dec-20 | 14.70 | 15.48 | 15.80 | 14.61 |
| Dec-23 | 15.49 | 16.51 | 16.83 | 15.13 |
| Dec-24 | 16.77 | 16.53 | 17.20 | 16.27 |
| Dec-26 | 16.33 | 16.93 | 17.02 | 15.98 |
| Dec-27 | 16.91 | 17.02 | 17.25 | 16.27 |
| Dec-30 | 16.91 | 16.58 | 16.91 | 16.01 |
| Dec-31 | 16.71 | 16.97 | 17.05 | 16.36 |
| Jan-2 | 17.17 | 17.07 | 18.22 | 16.95 |
| Jan-3 | 17.19 | 17.94 | 18.71 | 17.19 |
Arcturus Therapeutics Holdings Earnings
Arcturus Therapeutics Holdings Earnings Report: Per Share Arcturus Therapeutics Holdings Earnings Q1 Q2 Q3 and Q4 last year and next year.
Arcturus Therapeutics Holdings Forecast Revenue Growth
Arcturus Therapeutics Holdings Stock Analysis: Historical quarterly revenues per share for Arcturus Therapeutics Holdings and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.85 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.91 per share, and an increase next year of $2.25 per share.
* Arcturus Therapeutics Holdings stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.